China Grants Patent Protection to Microbix Biosystems Inc. for its Influenza Vaccine Yield Enhancement Technology

TORONTO, May 27 /CNW/ - Microbix Biosystems Inc. (TSX:MBX) has been granted a patent by the State Intellectual Property Office of the People's Republic of China for its VIRUSMAX(TM) technology which enables egg-based vaccine manufacturers to significantly increase the amount of influenza vaccine they produce each year.

Back to news